Apixaban CAS 503612-47-3
Identification
Properties
Safety Data
Specifications & Other Information
Links
Identification
CAS Number
503612-47-3
Name
Apixaban
Synonyms
1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxo-1-piperidinyl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridin-3-carboxamid [German] [ACD/IUPAC Name]
1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxo-1-piperidinyl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide [ACD/IUPAC Name]
1-(4-Méthoxyphényl)-7-oxo-6-[4-(2-oxo-1-pipéridinyl)phényl]-4,5,6,7-tétrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide [French] [ACD/IUPAC Name]
1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide
1H-Pyrazolo[3,4-c]pyridine-3-carboxamide, 4,5,6,7-tetrahydro-1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxo-1-piperidinyl)phenyl]- [ACD/Index Name]
503612-47-3 [RN]
Apixaban [INN] [USAN] [Wiki]
apixabanum [Latin] [INN]
BMS 562247-01
[503612-47-3]
1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide
1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxo-1-piperidinyl)phenyl]-4,5-dihydropyrazolo[3,4-c]pyridine-3-carboxamide
1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridine-3-carboxamide
1-(4-Methoxy-phenyl)-7-oxo-6-[4-(2-oxo-piperidin-1-yl)-phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-; 3-carboxylic acid amide
1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5-dihydropyrazolo[3,4-c]pyridine-3-carboxamide
205-514-0 [EINECS]
4,5,6,7-tetrahydro-1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxo-1-piperidinyl)phenyl]-1H-pyrazolo[3,4-c]pyridine-3-carboxamide
Apixaban (USAN/INN)
apixabanum
BMS-562247|Eliquis®
BMS562247-01
Eliquis [Trade name]
Eliquis®
GG2
MFCD00002708 [MDL number]
MFCD11977295 [MDL number]
OO 1750000
UNII-3Z9Y7UWC1J
Molecular Structure
SMILES
COC1=CC=C(C=C1)N2C3=C(CCN(C3=O)C4=CC=C(C=C4)N5CCCCC5=O)C(=N2)C(=O)N
StdInChI
InChI=1S/C25H25N5O4/c1-34-19-11-9-18(10-12-19)30-23-20(22(27-30)24(26)32)13-15-29(25(23)33)17-7-5-16(6-8-17)28-14-3-2-4-21(28)31/h5-12H,2-4,13-15H2,1H3,(H2,26,32)
StdInChIKey
QNZCBYKSOIHPEH-UHFFFAOYSA-N
Molecular Formula
C25H25N5O4
Molecular Weight
459.50
EINECS
205-514-0
MDL Number
MFCD00002708
Properties
Appearance
White powder
Specifications and Other Information of Our Apixaban CAS 503612-47-3
Standard
Enterprise standard
GMP
LCFDA
Basic Patent Situation
| US expiry date | 20230203 |
| EU expiry date | 20260517 |
| JP expiry date | 2026818 |
Identification Methods
HNMR/HPLC
Purity
98%min
Storage
Under the room temperature and away from light
Application
Used as the pharmaceutical API, primary prevention of thrombin generation and thrombus formation.
Links
Caming Pharmaceutical Ltd
This product is developed by our sub R&D company Caming Pharmaceutical Ltd, and please click the link below for details.
http://www.caming.com/apixaban-cas-503612-47-3/
Watson International Ltd
This product is sold exclusively through our sales company Watson International Ltd, and please click the link below for details.
http://www.watson-int.com/apixaban-cas-503612-47-3/